|
CAS |
Product Name |
中文名称 |
产品用途 |
|
2346620-54-8 |
((3aR,4R,6R,6aR)-2,2-dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl
isobutyrate |
((3aR,4R,6R,6aR)-2,2-dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl
isobutyrate |
MOLNUPIRAVIR INTERMEDIATES |
|
2346620-55-9 |
((3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl
isobutyrate |
((3AR,4R,6R,6AR)-6-(4-(羟氨)-2-恶嘧啶-1(2H)-甲基)-2,2-二甲基四氢呋喃[3,4-D][1,3]二氧醇-4-基)异丁酸甲酯 |
MOLNUPIRAVIR INTERMEDIATES |
|
2346620-53-7 |
((3aR,4R,6R,6aR)-6-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl
isobutyrate |
莫那比拉韦杂质12 |
MOLNUPIRAVIR INTERMEDIATES |
|
1006376-62-0 |
(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxamide |
(1R,2R)-2-(3，4-二氟苯基)环丙烷甲酰胺;替卡格雷中间体28 |
TICAGRELOR INTERMEDIATES |
|
220352-36-3 |
(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylic acid |
(1R,2S)-REL-2-(3,4-二氟苯基)环丙基甲酸;替格瑞洛相关化合物 |
TICAGRELOR INTERMEDIATES |
|
220352-38-5 |
(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine hydrochloride |
替格瑞洛杂质S（单体） |
TICAGRELOR INTERMEDIATES |
|
376608-71-8 |
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine
(2R)-Hydroxy(phenyl)ethanoate |
(1R,2S)-2-(3,4-二氟苯基)环丙胺
(R)-扁桃酸盐 |
TICAGRELOR INTERMEDIATES |
|
1006376-60-8 |
(1S)-2-chloro-1-(3,4-difluorophenyl)-1-ethanol |
(1S)-2-氯-1-(3,4-二氟苯基)乙醇 |
TICAGRELOR INTERMEDIATES |
|
207557-35-5 |
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile |
(2S)-N-氯乙酰基-2-氰基四氢吡咯 |
VILDAGLIPTIN INTERMEDIATES |
|
477600-70-7 |
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine |
顺式1-苄基-4-甲基-3-甲氨基-哌啶盐酸盐 |
TOFACITINIB INTERMEDIATES |
|
1062580-52-2 |
(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride |
(3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺盐酸盐 |
TOFACITINIB INTERMEDIATES |
|
1421372-94-2 |
(4-Fluoro-2-methoxy-5-nitro-phenyl)-[4-(1-methyl-1H-indol-3-yl)-pyrimidin-2-yl]-amine |
N-(4-氟-2-甲氧基-5-硝基苯基)-4-(1-甲基-1H-吲哚-3-基)-2-嘧啶胺 |
OSIMERTINIB INTERMEDIATES |
|
39263-34-8 |
(E)-N'-(2-cyano-4-nitrophenyl)-N,N-dimethylformimidamide |
N'-(2-氰基-4-硝基苯基)-N,N-二甲基甲脒 |
TUCATANIB INTERMEDIATES |
|
4009-98-7 |
(Methoxymethyl)triphenylphosphonium chloride |
(甲氧基甲基)三苯基氯化磷 |
TOFACITINIB INTERMEDIATES |
|
194032-32-1 |
(S)-1-BOC-2-METHYL-[1,4]DIAZEPANE |
(S)-1-BOC-2-甲基-[1,4]二氮杂环庚烷 |
RIPASUDIL INTERMEDIATES |
|
627502-58-3 |
(Z)-5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione |
5-(4-(2-(5-乙基吡啶-2-基)乙氧基)苯亚甲基)噻唑烷-2,4-二酮 |
PIOGLITAZONE INTERMEDIATES |
|
39025-23-5 |
(Z)-Guggulsterone |
孕二烯二酮 |
|
|
1029716-44-6 |
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
1-(1-乙氧基乙基)-4-吡唑硼酸频哪醇酯 |
RUXOLITINIB INTERMEDIATES |
|
575452-22-1 |
1-(1-ethoxyethyl)-4-iodo-1H-pyrazole |
1-(1-乙氧基乙基)-4-碘-1H-吡唑 |
RUXOLITINIB INTERMEDIATES |
|
603-76-9 |
1-methyl-1H-indole |
N-甲基吲哚 |
OSIMERTINIB INTERMEDIATES |
|
274693-55-9 |
2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
2-[[(3aR,4S,6R,6aS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧基]乙醇 |
TICAGRELOR INTERMEDIATES |
|
145783-12-6 |
2-(Propylthio)pyrimidine-4,6-diol |
2-(丙基硫基)嘧啶-4,6-二醇 |
TICAGRELOR INTERMEDIATES |
|
635702-60-2 |
2,3-dimethyl-2H-indazol-6-amine hydrochloride |
2,3-二甲基-6-氨基-2H-吲唑盐酸盐 |
PAZOPANIB INTERMEDIATES |
|
444731-73-1 |
2,3-dimethyl-6-nitro-2H-indazole |
2,3-二甲基-6-硝基吲唑 |
PAZOPANIB INTERMEDIATES |
|
3934-20-1 |
2,4-dichloropyrimidine |
2,4-二氯嘧啶 |
PAZOPANIB INTERMEDIATES |
|
17420-30-3 |
2-amino-5-nitrobenzonitrile |
2-氰基-4-硝基苯胺 |
TUCATANIB INTERMEDIATES |
|
410530-71-1 |
2-amino-6-chloropyrimidine-4(3H)-one |
2-氨基-6-氯-4-嘧啶醇水合物 |
|
|
51336-95-9 |
2-Chloro-1-(3,4-difluoro-phenyl)-ethanone |
2-氯-1-(3,4-二氟苯基)乙酮 |
TICAGRELOR INTERMEDIATES |
|
14394-70-8 |
2-chloro-5-methylpyrimidin-4-amine |
4-氨基-2-氯-5-甲基嘧啶 |
FEDRATINIB INTERMEDIATES |
|
1013916-37-4 |
2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
2-氯-8-环戊基-5-甲基-8H-吡啶并[2,3-D]嘧啶基-7-酮 |
PALBOCICLIB INTERMEDIATES |
|
403-24-7 |
2-fluoro-4-nitrobenzoic acid |
2-氟-4-硝基苯甲酸 |
ENZALUTAMIDE INTERMEDIATES |
|
1427-07-2 |
2-Fluoro-4-nitrotoluene |
2-氟-4-硝基甲苯 |
ENZALUTAMIDE INTERMEDIATES |
|
915087-24-0 |
2-Fluoro-N-methyl-4-nitrobenzamide |
N-甲基-2-氟-4-硝基苯甲酰胺 |
ENZALUTAMIDE INTERMEDIATES |
|
61676-62-8 |
2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2-异丙氧基-4,4,5,5-四甲基-1,3,2-二氧硼烷;异丙醇频哪醇硼酸酯 |
RUXOLITINIB INTERMEDIATES |
|
99-55-8 |
2-methyl-5-nitroaniline |
2-氨基-4-硝基甲苯 |
ENZALUTAMIDE INTERMEDIATES |
|
1032452-86-0 |
3-(2-chloropyrimidin-4-yl)-1-methyl-1H-indole |
3-(2-氯嘧啶-4-基)-1-甲基吲哚 |
OSIMERTINIB INTERMEDIATES |
|
330786-24-8 |
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
3-(4-苯氧苯基)-1H-4氨基-[3,4-D]吡唑并嘧啶；伊布替尼中间体N-2 |
IBRUTINIB INTERMEDIATE |
|
3680-71-5 |
3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one |
4-羟基吡咯并[2,3-d]嘧啶 |
|
|
330792-70-6 |
3-amino-4 cyano-5-(4-phenoxyphenyl) pyrazole |
3-氨基-5-(4-苯氧基苯基)-4-氰基-1H-吡唑 |
IBRUTINIB INTERMEDIATE |
|
27511-79-1 |
3-Amino-4-pyrazolecarboxamide hemisulfate salt |
3-氨基-4-甲酰胺基吡唑半硫酸盐 |
ALLOPURINOL INTERMEDIATES |
|
608523-94-0 |
3-amino-N-(tert-butyl)benzenesulfonamide |
N-叔丁基-3-氨基苯磺酰胺 |
FEDRATINIB INTERMEDIATES |
|
308283-47-8 |
3-bromo-N-(tert-butyl) benzene sulphonamide |
N-叔丁基-3-溴苯磺酰胺 |
FEDRATINIB INTERMEDIATES |
|
53249-76-6 |
3-chloro-2-methylbenzenethiol |
3-氯-2-甲基苯硫酚 |
|
|
7170-01-6 |
3-methyl-1H-1,2,4-triazole |
3-甲基-1H-1,2,4-噻唑 |
|
|
6494-19-5 |
3-methyl-6-nitro-2H-indazole |
3-甲基-6-硝基-1H-吲唑 |
PAZOPANIB INTERMEDIATES |
|
114393-97-4 |
4-(2-(5-ethylpyridin-2-yl)ethoxy)benzaldehyde |
4-[2-(5-乙基-2-吡啶基)乙氧基]苯甲醛 |
PIOGLITAZONE INTERMEDIATES |
|
50609-01-3 |
4-(2-(pyrrolidin-1-yl)ethoxy)aniline |
4-[2-(吡咯烷-1-基)乙氧基]苯胺 |
FEDRATINIB INTERMEDIATES |
|
145783-15-9 |
4,6-dichloro-2-(propylthio)pyrimidin-5-amine |
4,6-二氯
-2-(丙硫基)-5-氨基嘧啶 |
TICAGRELOR INTERMEDIATES |
|
145783-14-8 |
4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
4,6-二氯-5-硝基-2-丙硫基嘧啶 |
TICAGRELOR INTERMEDIATES |
|
1193-24-4 |
4,6-dihydroxypyrimidine |
4,6-二羟基嘧啶 |
|
|
915087-25-1 |
4-amino-2-fluoro-N-methylbenzamide |
N-甲基-2-氟-4-氨基苯甲酰胺 |
ENZALUTAMIDE INTERMEDIATES |
|
1024120-52-2 |
4-bromo-1-(1-ethoxyethyl)-1H-pyrazole |
4-溴-1-(1-乙氧基乙基)-1H-吡唑 |
RUXOLITINIB INTERMEDIATES |
|
2075-45-8 |
4-Bromopyrazole |
4-溴吡唑 |
RUXOLITINIB INTERMEDIATES |
|
3680-69-1 |
4-chloro-7H-pyrrolo[2 ,3-d]pyrimidine |
4-氯吡咯并嘧啶 |
TOFACITINIB INTERMEDIATES |
|
3680-69-1 |
4-chloro-7H-pyrrolo[2 ,3-d]pyrimidine |
4-氯吡咯并嘧啶 |
RUXOLITINIB INTERMEDIATES |
|
479633-63-1 |
4-chloro-7-tosyl-7-H-pyrrolo[2,3-d]pyrimidine |
4-氯-7-甲苯磺酰基-7H-吡咯[2,3-D]嘧啶 |
TOFACITINIB INTERMEDIATES |
|
1075705-01-9 |
4-fluoro-2-methoxy-5-nitroaniline |
4-氟-2-甲氧基-5-硝基苯胺 |
OSIMERTINIB INTERMEDIATES |
|
906820-08-4 |
4-Fluoro-5-isoquinolinesulfonyl chloride hydrochloride (1:1) |
4-氟异喹啉-5-磺酰氯盐酸盐 |
RIPASUDIL INTERMEDIATES |
|
194032-33-2 |
4-Fluoroisoquinoline-5-sulfonyl chloride hydrochloride |
4-氟异喹啉-5-磺酰氯 |
RIPASUDIL INTERMEDIATES |
|
315-30-0 |
4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine;Allopurinol |
别嘌醇 |
ALLOPURINOL INTERMEDIATES |
|
13721-01-2 |
4-Oxo-1,4-dihydro-quinoline-3-carboxylic acid |
4-氧代-1,4-二氢喹啉-3-羧酸 |
IVACAFTOR INTERMEDIATES |
|
269410-08-4 |
4-Pyrazoleboronic acid pinacol ester |
4-吡唑硼酸频哪醇酯 |
RUXOLITINIB INTERMEDIATES |
|
111025-46-8 |
5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione |
5-{4-[2-(5-乙基-2-吡啶基)乙氧基]苄基}-2,4-噻唑烷二酮;匹格列酮 |
PIOGLITAZONE INTERMEDIATES |
|
873055-58-4 |
5-Amino-2,4-di-tert-butyl-phenol |
5-氨基-2,4-二-叔丁基-苯酚 |
IVACAFTOR INTERMEDIATES |
|
6973-09-7 |
5-amino-2-methylbenzenesulfonamide |
5-氨基-2-甲基苯磺酰胺 |
PAZOPANIB INTERMEDIATES |
|
51-20-7 |
5-bromo uracil |
5-溴尿嘧啶 |
PALBOCICLIB INTERMEDIATES |
|
36082-50-5 |
5-Bromo-2,4-dichloropyrimidine |
5-溴-2,4-二氯嘧啶 |
PALBOCICLIB INTERMEDIATES |
|
733039-20-8 |
5-bromo-2-chloro-N-cyclopentylpyrimidin-4-amine |
5-溴-2-氯-N-环戊胺嘧啶-4胺 |
PALBOCICLIB INTERMEDIATES |
|
6945-68-2 |
5-bromo-3-nitropyridin-2-amine |
2-氨基-5-溴-3-硝基吡啶 |
|
|
1072-97-5 |
5-bromopyridin-2-amine |
2-氨基-5-溴吡啶 |
|
|
38875-53-5 |
5-bromopyridine-2,3-diamine |
2,3-二氨基-5-溴吡啶 |
|
|
936092-38-5 |
5-Methyl-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine |
5-Methyl-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine |
FEDRATINIB INTERMEDIATES |
|
145783-13-7 |
5-nitro-2-(propylthio)pyrimidine-4,6-diol |
5-硝基-2-(丙基硫代)嘧啶-4,6-二醇 |
TICAGRELOR INTERMEDIATES |
|
611-09-6 |
5-nitroindoline-2,3-dione |
5-硝基靛红 |
TUCATANIB INTERMEDIATES |
|
873-83-6 |
6-Aminouracil; 4-Amino-2,6-dihydroxypyrimidine, ;
6-Amino-2,4-pyrimidinediol |
4-氨基-2,6-二羟基嘧啶 |
6-AMINOURACIL |
|
1016636-76-2 |
6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
6-溴-2-氯-8-环戊基-5-甲基-吡啶并[2,3-D]嘧啶-7(8H)-酮 |
PALBOCICLIB INTERMEDIATES |
|
1228879-37-5 |
Benzyl-N,4-dimethylpiperidine-3-amine dihydrochloride |
N,4-二甲基-1-苄基-3-哌啶胺二盐酸盐 |
TOFACITINIB INTERMEDIATES |
|
2032-35-1 |
bromo acetaldehyde diethyl acetal |
溴代乙醛缩二乙醇 |
|
|
2052-01-9 |
Bromo Isobutyric acid |
2-溴代异丁酸 |
ENZALUTAMIDE INTERMEDIATES |
|
144689-94-1 |
diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate |
2-丙基-4,5-咪唑二羧酸二乙酯 |
OLMESARTAN INTERMEDIATES |
|
52133-67-2 |
Ethyl 2 –cyano-4,4-diethoxybutanoate |
2-氰基-4,4-二乙氧基丁酸乙酯 |
TOFACITINIB INTERMEDIATES |
|
144689-93-0 |
ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
4-(1-羟基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯 |
OLMESARTAN INTERMEDIATES |
|
73792-06-0 |
Ethyl 4-amino-2-fluorobenzoate; 2-Fluoro-4-aminobenzoic acid
ethyleste |
4-氨基-2-氟苯甲酸乙酯 |
ENZALUTAMIDE INTERMEDIATES |
|
873054-44-5 |
Ivacaftor;
N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-
quinolinecarboxamide |
依伐卡托;
N-(2,4-二叔丁基-5-羟基苯基)-1,4-二氢-4-氧代-3-喹啉甲酰胺 |
IVACAFTOR INTERMEDIATES |
|
444731-74-2 |
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine |
N-(2-氯嘧啶-4-基)-2,3-二甲基-2H-吲唑-6-胺 |
PAZOPANIB INTERMEDIATES |
|
444731-75-3 |
N-(2-chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine |
N-(2-氯嘧啶-4-基)-N-甲基-2,3-二甲基-2H-吲唑-6-胺 |
PAZOPANIB INTERMEDIATES |
|
1421372-67-9 |
N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine |
N-(2-二甲基氨基-乙基)-2-甲氧基-n-甲基-n-[4-(1-甲基-1H-吲哚-3-基)-嘧啶-2-基]-5-硝基-苯-1,4-二胺 |
OSIMERTINIB INTERMEDIATES |
|
68076-36-8 |
N-Boc-1,4-butanediamine |
N-叔丁氧羰基-1,4-丁二胺 |
|
|
477600-74-1 |
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 |
TOFACITINIB INTERMEDIATES |
|
13754-38-6 |
phenyl(piperazin-1-yl)methanone |
1-苯甲酰哌嗪 |
|
|
330792-68-2 |
Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene] |
2-[羟基(4-苯氧基苯基)亚甲基]丙二腈 |
IBRUTINIB INTERMEDIATE |
|
1799799-87-3 |
tert-butyl (E)-4-(3-(dimethylamino)acryloyl)piperidine-1-carboxylate |
反式4-(3-(二甲基氨基)丙烯酰基)哌啶-1-羧酸叔丁酯 |
ZANUBRUTINIB INTERMEDIATES |
|
2190506-55-7 |
tert-butyl
4-(3-cyano-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate;Zanubrutinib
Impurity |
泽布替尼杂质 |
ZANUBRUTINIB INTERMEDIATES |
|
571188-82-4 |
tert-butyl
4-(6-((6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
4-[6-[(6-溴-8-环戊基-7,8-二氢-5-甲基-7-氧代吡啶并[2,3-d]嘧啶-2-基)氨基]-3-吡啶基]-1-哌嗪羧酸叔丁酯 |
PALBOCICLIB INTERMEDIATES |
|
571188-59-5 |
tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate |
4-(6-氨基吡啶-3-基)哌嗪-1-羧酸叔丁酯 |
PALBOCICLIB INTERMEDIATES |
|
2295-31-0 |
thiazolidine-2,4-dione |
2,4-噻唑烷二酮 |
PIOGLITAZONE INTERMEDIATES |
|
144690-92-6 |
Tritylolmesartan medoxomil; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate |
三苯甲基奥美沙坦酯 |
OLMESARTAN INTERMEDIATES |
